SI0862431T1 - Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate - Google Patents
Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanateInfo
- Publication number
- SI0862431T1 SI0862431T1 SI9630410T SI9630410T SI0862431T1 SI 0862431 T1 SI0862431 T1 SI 0862431T1 SI 9630410 T SI9630410 T SI 9630410T SI 9630410 T SI9630410 T SI 9630410T SI 0862431 T1 SI0862431 T1 SI 0862431T1
- Authority
- SI
- Slovenia
- Prior art keywords
- amoxycillin
- paediatric
- clavulanate
- pharmaceutical formulation
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US335395P | 1995-09-07 | 1995-09-07 | |
| PCT/US1996/014554 WO1997009042A1 (en) | 1995-09-07 | 1996-09-05 | Pharmaceutical formulation |
| EP96930817A EP0862431B1 (en) | 1995-09-07 | 1996-09-05 | Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0862431T1 true SI0862431T1 (en) | 2002-06-30 |
Family
ID=21705455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9630410T SI0862431T1 (en) | 1995-09-07 | 1996-09-05 | Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US6726908B2 (xx) |
| EP (3) | EP1093812A3 (xx) |
| JP (1) | JP3501289B2 (xx) |
| KR (1) | KR100495585B1 (xx) |
| CN (1) | CN1289084C (xx) |
| AR (1) | AR004510A1 (xx) |
| AT (1) | ATE208618T1 (xx) |
| AU (1) | AU711441B2 (xx) |
| BR (1) | BR9610396A (xx) |
| CA (1) | CA2231194C (xx) |
| CO (1) | CO4750658A1 (xx) |
| CY (1) | CY2359B1 (xx) |
| CZ (1) | CZ299595B6 (xx) |
| DE (1) | DE69617036T2 (xx) |
| DK (1) | DK0862431T3 (xx) |
| ES (1) | ES2165997T3 (xx) |
| HK (2) | HK1043042A1 (xx) |
| HU (1) | HUP9901437A3 (xx) |
| IL (1) | IL123563A (xx) |
| NO (1) | NO314831B1 (xx) |
| NZ (3) | NZ318282A (xx) |
| PL (1) | PL325411A1 (xx) |
| PT (1) | PT862431E (xx) |
| SI (1) | SI0862431T1 (xx) |
| TR (1) | TR199800415T1 (xx) |
| TW (1) | TW501926B (xx) |
| WO (1) | WO1997009042A1 (xx) |
| ZA (1) | ZA967546B (xx) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030109503A1 (en) * | 1995-06-06 | 2003-06-12 | Smithkline Beecham P.L.C. | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
| DE69617036T2 (de) * | 1995-09-07 | 2002-07-11 | Smithkline Beecham Corp | Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung |
| GB9617780D0 (en) * | 1996-08-24 | 1996-10-02 | Smithkline Beecham Plc | Method of treatment |
| US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
| CO5170471A1 (es) * | 1999-04-13 | 2002-06-27 | Beecham Pharmaceutical Pte Ltd | Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio |
| GB2365337A (en) * | 1999-04-13 | 2002-02-20 | Beecham Pharma | Amoxycillin and potassium clavulanate high dosage regimen |
| US7250176B1 (en) * | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
| US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
| AU5241200A (en) * | 1999-06-29 | 2001-01-31 | Miciopharma Chemical Aktiengesellschaft | Retard formulation of amoxicillin for oral administration |
| US7838032B2 (en) | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
| US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
| US7985420B2 (en) | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
| US8012504B2 (en) | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
| US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
| EP1330236A2 (en) | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
| PT1492511E (pt) | 2002-04-09 | 2009-04-09 | Flamel Tech Sa | Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s) |
| KR100456833B1 (ko) * | 2002-08-01 | 2004-11-10 | 주식회사 대웅 | 아목시실린 및 클라불라네이트를 함유하는 유핵정 |
| US8614315B2 (en) | 2009-12-25 | 2013-12-24 | Mahmut Bilgic | Cefdinir and cefixime formulations and uses thereof |
| TR200909787A2 (tr) | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar. |
| TR201000688A2 (tr) | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar. |
| TR201000686A1 (tr) | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@ |
| TR201000687A1 (tr) | 2010-01-29 | 2011-08-22 | Bi̇lgi̇ç Mahmut | Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar |
| WO2013057569A2 (en) | 2011-10-19 | 2013-04-25 | Micro Labs Limited | Extended release pharmaceutical composition containing amoxicillin and clavulanic acid |
| MX2014008375A (es) * | 2012-01-10 | 2017-07-27 | Spector Michael | Formulaciones pedriaticas de supspension oral de amoxicilina y clauvulanato de potasio y metodo para su uso. |
| WO2013173803A2 (en) * | 2012-05-17 | 2013-11-21 | Michael Spector | Formulations of amoxicillin and clavulanate potassium and methods for using same |
| WO2013173808A2 (en) * | 2012-05-17 | 2013-11-21 | Michael Spector | Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use |
| US11278506B2 (en) | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ177159A (en) * | 1974-04-20 | 1978-03-06 | Beecham Group Ltd | Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions |
| JO984B1 (en) * | 1977-10-11 | 1979-12-01 | بيتشام غروب ليمتد | A dry pharmaceutical compound with a suitable dosage unit for oral administration |
| IL58461A0 (en) | 1978-10-27 | 1980-01-31 | Beecham Group Ltd | Intramammary compositions comprising a clavulanic acid salt |
| NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
| EP0080862B1 (en) * | 1981-12-02 | 1985-09-25 | Beecham Group Plc | Pharmaceutical formulation comprising beta-lactam antibiotics |
| US4673637A (en) | 1984-04-23 | 1987-06-16 | Hyman Edward S | Method for detecting bacteria in urine and for treating rheumatoid arthritis, essential hypertension and other diseases associated with bacteriuria |
| DE3887179T2 (de) | 1987-03-02 | 1994-06-16 | Brocades Pharma Bv | Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung. |
| US5114929A (en) | 1989-03-21 | 1992-05-19 | Beecham Group P.L.C. | Pharmaceutical formulation |
| GB8909793D0 (en) | 1989-04-28 | 1989-06-14 | Beecham Group Plc | Pharmaceutical formulation |
| KR910009271B1 (ko) | 1989-06-20 | 1991-11-08 | 김영설 | 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염 |
| GB9007945D0 (en) * | 1990-04-07 | 1990-06-06 | Beecham Group Plc | Pharmaceutical formulation |
| US5814337A (en) * | 1992-10-07 | 1998-09-29 | Beecham Group Plc | Pharmaceutical formulation |
| GB9109862D0 (en) | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
| GB9114950D0 (en) | 1991-07-11 | 1991-08-28 | Smithkline Beecham Plc | Pharmaceutical formulation |
| AU5863894A (en) * | 1993-01-22 | 1994-08-15 | Smithkline Beecham Plc | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
| GB9311030D0 (en) | 1993-05-28 | 1993-07-14 | Smithkline Beecham Corp | Pharmaceutical formulations |
| IL109770A0 (en) * | 1993-05-29 | 1994-11-28 | Smithkline Beecham Corp | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby |
| GB9405856D0 (en) | 1994-03-24 | 1994-05-11 | Smithkline Beecham Plc | Pharmaceutical formulation |
| GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
| GB9408117D0 (en) | 1994-04-23 | 1994-06-15 | Smithkline Beecham Corp | Pharmaceutical formulations |
| ITMI941169A1 (it) | 1994-06-06 | 1995-12-06 | Smithkline Beecham Farma | Formulazioni farmaceutiche |
| US5567439A (en) | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
| GB9416599D0 (en) | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
| GB9416600D0 (en) | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
| DZ1926A1 (fr) | 1994-09-03 | 2002-02-17 | Smithkline Beckman P L C | Formulations pharmaceutiques. |
| DZ2028A1 (fr) | 1995-05-03 | 2002-10-23 | Smithkline Beecham Plc | Médicaments destinés au traitement d'infections bactériennes en pédiatrie. |
| US5830073A (en) | 1995-07-28 | 1998-11-03 | Voss; Brian C. | Bowling lane surfaces |
| DE69617036T2 (de) * | 1995-09-07 | 2002-07-11 | Smithkline Beecham Corp | Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung |
| EA002595B1 (ru) | 1997-02-14 | 2002-06-27 | Смитклайн Бичем Лаборатуар Фармасетик | Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат |
| SE9700885D0 (sv) | 1997-03-12 | 1997-03-12 | Astra Ab | New pharmaceutical formulation |
| KR20000076329A (ko) | 1997-03-25 | 2000-12-26 | 다케다 야쿠힌 고교 가부시키가이샤 | 위장 점막 부착성 약제 조성물 |
| GB9815532D0 (en) | 1998-07-17 | 1998-09-16 | Lek Pharmaceutical & Cvhemical | Pharmaceutical suspension formulation |
| GB9818927D0 (en) | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Pharmaceutical formulation |
| CO5170471A1 (es) * | 1999-04-13 | 2002-06-27 | Beecham Pharmaceutical Pte Ltd | Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio |
-
1996
- 1996-09-05 DE DE69617036T patent/DE69617036T2/de not_active Revoked
- 1996-09-05 HU HU9901437A patent/HUP9901437A3/hu not_active Application Discontinuation
- 1996-09-05 EP EP00203970A patent/EP1093812A3/en not_active Ceased
- 1996-09-05 TR TR1998/00415T patent/TR199800415T1/xx unknown
- 1996-09-05 KR KR10-1998-0701743A patent/KR100495585B1/ko not_active IP Right Cessation
- 1996-09-05 AT AT96930817T patent/ATE208618T1/de not_active IP Right Cessation
- 1996-09-05 EP EP96930817A patent/EP0862431B1/en not_active Revoked
- 1996-09-05 PL PL96325411A patent/PL325411A1/xx unknown
- 1996-09-05 BR BR9610396A patent/BR9610396A/pt not_active Application Discontinuation
- 1996-09-05 CN CNB961978791A patent/CN1289084C/zh not_active Expired - Lifetime
- 1996-09-05 NZ NZ318282A patent/NZ318282A/xx not_active IP Right Cessation
- 1996-09-05 WO PCT/US1996/014554 patent/WO1997009042A1/en not_active Application Discontinuation
- 1996-09-05 AU AU69733/96A patent/AU711441B2/en not_active Expired
- 1996-09-05 PT PT96930817T patent/PT862431E/pt unknown
- 1996-09-05 SI SI9630410T patent/SI0862431T1/xx unknown
- 1996-09-05 AR ARP960104241A patent/AR004510A1/es not_active Application Discontinuation
- 1996-09-05 DK DK96930817T patent/DK0862431T3/da active
- 1996-09-05 NZ NZ337247A patent/NZ337247A/en not_active IP Right Cessation
- 1996-09-05 CA CA002231194A patent/CA2231194C/en not_active Expired - Lifetime
- 1996-09-05 CZ CZ0068398A patent/CZ299595B6/cs not_active IP Right Cessation
- 1996-09-05 JP JP51146197A patent/JP3501289B2/ja not_active Expired - Lifetime
- 1996-09-05 EP EP01201824A patent/EP1147771A1/en not_active Ceased
- 1996-09-05 ES ES96930817T patent/ES2165997T3/es not_active Expired - Lifetime
- 1996-09-05 IL IL12356396A patent/IL123563A/en not_active IP Right Cessation
- 1996-09-06 ZA ZA9607546A patent/ZA967546B/xx unknown
- 1996-09-06 CO CO96047585A patent/CO4750658A1/es unknown
- 1996-10-16 TW TW085110884A patent/TW501926B/zh not_active IP Right Cessation
-
1997
- 1997-10-27 US US08/722,259 patent/US6726908B2/en not_active Expired - Lifetime
-
1998
- 1998-03-06 NO NO19981008A patent/NO314831B1/no not_active IP Right Cessation
-
1999
- 1999-03-02 HK HK02102227.9A patent/HK1043042A1/zh unknown
- 1999-03-02 HK HK99100869A patent/HK1015701A1/xx not_active IP Right Cessation
- 1999-08-13 NZ NZ337246A patent/NZ337246A/xx not_active IP Right Cessation
-
2001
- 2001-02-20 US US09/788,948 patent/US20010038838A1/en not_active Abandoned
-
2003
- 2003-05-07 CY CY0300039A patent/CY2359B1/xx unknown
- 2003-11-21 US US10/719,211 patent/US20050261267A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI0862431T1 (en) | Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate | |
| HK1050992A1 (zh) | 含有藥物配方的阿莫西林和克拉維酸 | |
| IL131201A (en) | Pharmaceutical formulations comprising amoxycillin and clavulanate | |
| AU3777597A (en) | Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient | |
| AU5538098A (en) | A slow releasing physiologically active pharmaceutical and method of preparation thereof | |
| AU6042696A (en) | Drug delivery catheters and methods of use | |
| AU6501296A (en) | Method and apparatus of enhancing the delivery of a pharmaceutical formulation | |
| AU4022697A (en) | Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia | |
| HK1009101A1 (en) | Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients | |
| AU7294196A (en) | Stable pharmaceutical forms of administration containing parathormone | |
| AU2230692A (en) | Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof | |
| IL115125A0 (en) | Pharmaceutical formulations comprising derivatives of clavulanic acid | |
| IL102003A0 (en) | Pharmaceutical formulation of a benzodiazepine | |
| AU6318896A (en) | Benzamidoxime derivatives and medicinal use thereof | |
| AU5739499A (en) | Pharmaceutical formulation of sodium amoxycillin and potassium clavulanate | |
| AU3363193A (en) | Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative | |
| GB9304745D0 (en) | Use of pharmaceutical formulations | |
| ZA951789B (en) | Pharmaceutical materials and methods of administration | |
| AU5841696A (en) | Preparation and use of contrast agents | |
| ZA948192B (en) | Pharmaceutical formulation of aspirin and sallcylates | |
| SI0825860T1 (en) | Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients | |
| AU1401895A (en) | Triflate-mediated preparation and use of iodonium compounds | |
| ZA969474B (en) | Potentiation of analgesic anti-inflammatory and anti-pyrit-ic drugs | |
| GB9507677D0 (en) | Pharmaceutical formulation and dose | |
| HUP0001584A3 (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate |